Gsa Capital Partners LLP Nevro Corp Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $401,097 - $697,222	17,732 Added 131.57%	31,209 $793,000
Q1 2023 May 12, 2023	SELL	$30.17 - $41.11 $583,065 - $794,491	-19,326 Reduced 58.92%	13,477 $487,000
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $1.2 Million - $1.62 Million	32,803 New	32,803 $1.3 Million
Q2 2022 Aug 09, 2022	BUY	$40.85 - $77.67 $253,229 - $481,476	6,199 New	6,199 $272,000
Q1 2021 May 10, 2021	SELL	$132.81 - $182.18 $322,197 - $441,968	-2,426 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$138.17 - $184.34 $335,200 - $447,208	2,426 New	2,426 $420,000
Q1 2020 May 12, 2020	SELL	$70.23 - $144.31 $188,497 - $387,328	-2,684 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$76.41 - $117.54 $205,084 - $315,477	2,684 New	2,684 $315,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.